Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation

Fig. 1

Puerarin improves glucose metabolism, liver dysfunction, and hyperlipidemia in MAFLD mice. (A) Flowchart of this investigation. (B) Body weights of mice in the Control + Vehicle, Control + Puerarin, MAFLD + Vehicle, and MAFLD + Puerarin groups. (C) Intraperitoneal glucose tolerance test (IPGTT) results and area under the curve. (D) Intraperitoneal insulin tolerance test (IPITT) results and area under the curve. (E-H). Measurement of total cholesterol (TC), triglyceride (TG), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels in control and MAFLD mice treated with vehicle or puerarin. The data are expressed as the mean ± SD (n = 6). *P < 0.05, **P < 0.01, ***P < 0.001 versus Control + Vehicle. #P < 0.05, ##P < 0.01, ###P < 0.001 versus MAFLD + Vehicle.

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X